‘Ozempic drugs’ reduce obesity-associated cancer risk by up to 65%
The GLP-1RA class of drugs, which includes Ozempic, reduces the risk of 10 out of 13 obesity-associated cancers. Depositphotos – By Paul McClure 2024 Jul 07 – The popular class of antidiabetic and weight loss drugs known as GLP-1RAs, which includes Ozempic and Wegovy, …